Clinical trial Recruiting at 1 site Interventional Ages 18 to 64 Women only

Using Twizzlers to screen for gestational diabetes

Official title: Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial

Run by Baylor College of Medicine · NCT02610179 · Data updated 2026-11-12

This study is testing if eating 10 Twizzlers can be a good way to check for gestational diabetes in pregnant women, instead of the usual sugary drink.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexWomen only
Enrollment617 (estimated)
SponsorBaylor College of Medicine
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedApril 2015
Main results expectedJanuary 2025
Study endsMarch 2027
Registry record updatedMay 11, 2023
Trial IDNCT02610179 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women between 24 to 28 weeks of gestation who are willing to participate.

Probably not a fit

Patients with known Type I or Type II diabetes, those on corticosteroids, or those with a previous high glucola screening result will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective trial aims to evaluate the effectiveness of consuming 10 Twizzlers as an alternative to the standard 50 gram glucola beverage for screening gestational diabetes mellitus (GDM) in pregnant women. Participants will be recruited from the Harris Health System Obstetrics Clinics and will have their blood glucose levels measured one hour after consuming the Twizzlers. The study will compare the sensitivity, specificity, and predictive values of the Twizzlers challenge against the glucola beverage, providing insights into a potentially cost-effective screening method for GDM. The trial will also assess the need for follow-up glucose tolerance tests based on the results of the screenings.

Why it matters

Potential benefit: If successful, this study could provide a more palatable and cost-effective method for screening gestational diabetes, improving patient compliance and outcomes.

How similar studies have gone: While the use of alternative screening methods for gestational diabetes is not widely tested, this approach is novel and could provide new insights into effective screening practices.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant
* 24 to 28 weeks gestation
* Singleton or twin or triplet gestation
* Willing to participate in the study

Exclusion Criteria:

* Known Type II DM
* Known Type I DM
* On oral or injectable corticosteroids
* 50 gram glucola beverage GCT of greater than or equal to 190 mg/dl

Where it's running

  • Ben Taub General Hospital
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Kjersti Aagaard, MD, PhD — Baylor College of Medicine
  • Study coordinator: Kjersti Aagaard, MD, PhD
  • Email: aagaardt@bcm.edu
  • Phone: 713-798-8467

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.